Skip to main content
. 2019 Apr 11;12:2767–2776. doi: 10.2147/OTT.S197740

Figure 2.

Figure 2

Clinical significance of miR-125b in patients with CC. (A) Comparison of miR-125b expression levels between patients with metastatic and non-metastatic CC. (B) Comparison of miR-125b expression levels between patients with relapsed and non-relapsed CC. (C) The OS of the CC patients with low and high expression levels of miR-125b. (D) The PFS of the CC patients with low and high expression levels of miR-125b; *P<0.05.

Abbreviations: CC, cervical cancer; OS, overall survival; PFS, progression-free survival.